Hepatocellular Carcinoma: To Biopsy or Not?

Article Type
Changed
Thu, 12/15/2022 - 15:10
Display Headline
Hepatocellular Carcinoma: To Biopsy or Not?
Case in Point

Article PDF
Author and Disclosure Information

James M. Abraham, MD; and Christine Pocha, MD, PhD

Dr. Abraham is a gastroenterology fellow at the University of Minnesota, Minneapolis. Dr. Pocha is the co-director of the Hepatitis C Resource Center at the Minneapolis VA Health Care System and an assistant professor in the department of medicine at the University of Minnesota.

Issue
Federal Practitioner - 28(8)
Publications
Topics
Page Number
34
Legacy Keywords
hepatocellular carcinoma, HCC, liver cancer, needle biopsy, hepatitis C, Minneapolis VA Health Care System, genotype 3a, Metavir classification, radiofrequency ablation, RFA, transarterial chemoembolization, TACE, palliative radiation therapy, American Association for the Study of Liver Disease, European Association for the Study of the Liver, needle track seedinghepatocellular carcinoma, HCC, liver cancers, needle biopsy, hepatitis C, Minneapolis VA Health Care System, genotype 3a, Metavir classification, radiofrequency ablation, RFA, transarterial chemoembolization, TACE, palliative radiation therapy, American Association for the Study of Liver Disease, European Association for the Study of the Liver, needle track seeding
Sections
Author and Disclosure Information

James M. Abraham, MD; and Christine Pocha, MD, PhD

Dr. Abraham is a gastroenterology fellow at the University of Minnesota, Minneapolis. Dr. Pocha is the co-director of the Hepatitis C Resource Center at the Minneapolis VA Health Care System and an assistant professor in the department of medicine at the University of Minnesota.

Author and Disclosure Information

James M. Abraham, MD; and Christine Pocha, MD, PhD

Dr. Abraham is a gastroenterology fellow at the University of Minnesota, Minneapolis. Dr. Pocha is the co-director of the Hepatitis C Resource Center at the Minneapolis VA Health Care System and an assistant professor in the department of medicine at the University of Minnesota.

Article PDF
Article PDF
Case in Point
Case in Point

Issue
Federal Practitioner - 28(8)
Issue
Federal Practitioner - 28(8)
Page Number
34
Page Number
34
Publications
Publications
Topics
Article Type
Display Headline
Hepatocellular Carcinoma: To Biopsy or Not?
Display Headline
Hepatocellular Carcinoma: To Biopsy or Not?
Legacy Keywords
hepatocellular carcinoma, HCC, liver cancer, needle biopsy, hepatitis C, Minneapolis VA Health Care System, genotype 3a, Metavir classification, radiofrequency ablation, RFA, transarterial chemoembolization, TACE, palliative radiation therapy, American Association for the Study of Liver Disease, European Association for the Study of the Liver, needle track seedinghepatocellular carcinoma, HCC, liver cancers, needle biopsy, hepatitis C, Minneapolis VA Health Care System, genotype 3a, Metavir classification, radiofrequency ablation, RFA, transarterial chemoembolization, TACE, palliative radiation therapy, American Association for the Study of Liver Disease, European Association for the Study of the Liver, needle track seeding
Legacy Keywords
hepatocellular carcinoma, HCC, liver cancer, needle biopsy, hepatitis C, Minneapolis VA Health Care System, genotype 3a, Metavir classification, radiofrequency ablation, RFA, transarterial chemoembolization, TACE, palliative radiation therapy, American Association for the Study of Liver Disease, European Association for the Study of the Liver, needle track seedinghepatocellular carcinoma, HCC, liver cancers, needle biopsy, hepatitis C, Minneapolis VA Health Care System, genotype 3a, Metavir classification, radiofrequency ablation, RFA, transarterial chemoembolization, TACE, palliative radiation therapy, American Association for the Study of Liver Disease, European Association for the Study of the Liver, needle track seeding
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media